(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TERAPIA GÊNICA DE VÍRUS ADENOASSOCIADO PARA DEFICIÊNCIA DE 21-HIDROXILASE

ArquivadaInvention PatentPCT · US2019013991

Application data

Number

112020014404

Type

Invention Patent

Filing

01/17/2019

Publication

12/29/2020

PCT

US2019013991

Progress at the INPI

  1. Filing01/17/19
  2. Publication12/29/20
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/17/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ADRENAS THERAPEUTICS, INC.

US

Inventors

G. G. (pessoa física)

US

P. B. (pessoa física)

US

Technical data

Priority claims

US

62/618,307 · 01/17/2018

US

62/640,311 · 03/08/2018

Abstract

São divulgados aqui vetores virais adenoassociados recombinantes que expressam a proteína 21-hidroxilase (21OH) e usos relacionados para tratar deficiência de 21OH.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento - Art. 36 §1° da LPI

#11.2

03/17/2026

RPI 2880

Parecer de pré-exame

#6.23

11/25/2025

RPI 2864

Adição na publicação

#15.35

12/14/2021

RPI 2658

Notificação de entrada na fase nacional - PCT

#1.3

12/29/2020

RPI 2608

Alteração de dados cadastrais

#1.1

10/20/2020

RPI 2598

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.